SCHEMBL24317210

SCHEMBL24317210

COc1cc(N2CCN(C)c3cc(C4=CCN(I)CC4)c(C#N)cc32)c2cc(C)c(=O)n(C)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29471224 0.93 SLC6A4 (0.35) —
SCHEMBL24317132 0.93 SLC6A4 (0.35) —
SCHEMBL24317208 0.82 MAPT (0.34) —
SCHEMBL26549131 0.82 MAOA (0.34) —
SCHEMBL24316893 0.80 KCNH2 (0.33) —
SCHEMBL24316865 0.80 GABRA1 (0.35) —
SCHEMBL24317119 0.80 POLB (0.34) —
SCHEMBL24317131 0.80 EGFR (0.32) —
SCHEMBL24317120 0.80 FGFR1 (0.32) —
SCHEMBL24316602 0.80 CREBBP (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053967-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2022-03-17 — — WO disclosed
Send feedback